Abstract
The prevalence of mild cognitive impairment (MCI) and dementia in maintenance hemodialysis (MHD) patients is significant higher than common population. Several studies showed that amyloid β-protein (Aβ) levels in cerebrospinal fluid or plasma were closely associated with cognition function. However, few studies focused on the relationship between cognitive function and plasma Aβ levels in MHD patients. This study aimed to investigate the prevalence, plasms Aβ levels and potent risk factors of MCI and dementia in MHD patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.